A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

A collaborative study from the University of Cologne has uncovered how a key mitochondrial protein, AIFM1 (Apoptosis-Inducing ...

Many people with IBD, an umbrella term that includes ulcerative colitis and Crohn's disease, have a reduced quality of life, ...

The theft probably helps the cells to spread around the body, and preventing it could provide a path to treatment, ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Drug resistance in solid tumors remains a major obstacle in oncology, frequently leading to treatment failure and disease relapse. A central contributor to ...

Immune checkpoint inhibitors transformed the treatment landscape of extensive-stage small-cell lung cancer (ES-SCLC) in 2019 and have since become the standard of care in the first-line setting. 1–3 ...

Bottom-up artificial cells have been widely studied in fundamental life sciences and other valuable applications. However, common one-pot encapsulation construction strategies usually result in ...

Quantitative metabolomics (qMetabolomics) is a powerful tool for understanding the intricate metabolic processes involved in plant abiotic stress responses. qMetabolomics is hindered by the limited ...

Dreyling M, Doorduijn J, Giné E, et al: Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.